IL17A and Alzheimer disease: Linking to this, a single in vivo study was identified where both oxazolone and TPA-induced AD mouse models using IL-17−/− and WT Balb/c mice suggested that IL-17 contributes to abnormal distribution of lamellar bodies in the skin, accompanied by edema, and TEWL [42].